GF
Gemma Frisius Fund
Venture CapitalActiveOn July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture
21
Investments
4
Exits
—
AUM
19.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Gemma Frisius Fund.
Investment Thesis & Strategy
Gemma Frisius Fund invests in various stages across a broad range of industries, likely seeking innovative companies with high growth potential.
Investment Activity
Deals per year over the last 11 years
1
20100
20111
20121
20130
20141
20150
20162
20175
20180
20191
2020Portfolio Companies
Selected investments from their portfolio of 21 companies
A
Aphea.Bio
Biotech · Seed, 2020
V
ViroVet
Biotech · Series A, 2018
V
Vesale Pharma
Healthcare · Growth, 2018
R
Rejuvenate Biomed
Biotech · Series A, 2018
P
Precirix
Biotech · Series A, 2018
I
Inbiose
Biotech · Series A, 2018
A
Agomab Therapeutics
Biotech · Series A, 2017
O
Oncomfort
Healthcare · Series A, 2017
C
Complix
Biotech · Series A, 2015
B
Biotalys
Biotech · Series A, 2013
e
e-Xstream
Enterprise · Growth, 2012
X
Xenikos
Biotech · Series A, 2010
Frequently Asked Questions
Gemma Frisius Fund focuses on Series A, Series B, Series C+ stage investments.